Live
- South Korea reports new avian influenza case at regional farm
- US egg prices soar to yearly high amid bird flu, holiday demand
- Ayushman Bharat proving to be boon for people in Gujarat's Kheda
- SEBI takes strict action in front running case, bars 9 entities, seizes over Rs 21 crore (Lead)
- Grand 30th Alumni Reunion at Vattam Jawahar Navodaya Vidyalaya
- Tensions Erupt Outside Allu Arjun's Residence as OU JAC Stages Protest
- DMK adopts resolution condemning Amit Shah's remarks on Ambedkar
- Truck Driver Brutally Murdered in Mulugu District
- Telangana State Cross Country Championship 2024 Successfully Conducted in Kalwakurthy
- Odisha: Collectors asked for proper assessment of crop loss due to unseasonal rainfall
Sputnik Light vax: Hetero arm gets CDSCO approval
Sputnik Light vax: Hetero arm gets CDSCO approval
Drug firm Hetero on Monday said its biologics arm has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell Sputnik Light for restricted emergency use in India.
Hyderabad: Drug firm Hetero on Monday said its biologics arm has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell Sputnik Light for restricted emergency use in India.
Hetero is the first biopharmaceutical company in India to receive Manufacturing and Marketing (M&M) approval for the product manufactured locally for the prevention of Covid-19 in adults aged over 18 years, administered in a single dose of 0.5 ml, the company said in a statement.
All other currently approved vaccines in India require two doses of administration, it added. Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V – the world's first registered vaccine against Covid-19.
In February 2022, the Drugs Controller General of India (DCGI) granted emergency use permission to single-dose Sputnik Light Covid-19 vaccine in India.
